New Results utilizes the generic equivalent to these drugs, called Semaglutide. We source Semaglutide, and many other products/drugs that we offer, from U.S. based Compounding Pharmacies that are FDA monitored.

Many insurance companies may cover Semaglutide, however, it is generally NOT covered in non-diabetic patients, and many insurance companies place other restrictions on coverage. As of September 2024, many large retailers (Walmart, CVS, Walgreens) are charging, on average, $1250-$1500 or more for Ozempic. New Results offers Semaglutide treatment at a MUCH lower price. We offer very affordable rates for trying semaglutide with our in-office injections. Prices range from 10-2o units for $75 to 70-80 units for $125. Please call our office for more information and to get started today!

Although this class of medications, called GLP-1 agonists (Glucagon Like Peptide – 1 agonists), was originally developed to treat type 2 diabetes, according to the American Academy of Family Physicians, “once-weekly Semaglutide is an effective adjunct for weight loss in adults without diabetes who are overweight or obese” (AAFP 2021; 104: 96-97)

Ozempic is only approved by the FDA for the treatment of type 2 diabetes – Wegovy does have a weight loss indication. However, people who do not have diabetes may be able to take Semaglutide “off-label” with a prescription from their doctor. At New Results, our medical director will determine in each patient if treatment with Semaglutide is appropriate.

For patients taking Semaglutide for weight loss due to obesity, or being overweight, it can be stopped when the benefits are no longer needed (weight loss goal is achieved). The amount of time it is taken, and the rate of weight loss varies from patient to patient. Many factors are involved – how much weight a patient has to lose, the dose required to produce the desired effects (appetite suppression and weight loss), etc. In clinical studies, patients lost 10-20% of their body weight (in a 200-pound person, that would be up to 40 pounds). The FDA recommends that the dosage of Semaglutide must be increased to its effective level of 2.4mg during the 16-20 weeks of therapy to include its weight loss benefits (please note, New Results generally see weight loss at lower doses, and our goal is to use the lowest dose possible to see the weight loss benefits.

Some experts believe that rebound weight gain can be common after stopping Semaglutide because the drug is no longer working in the body. But, like anyone who loses a significant amount of weight, it is important to maintain lifestyle changes – such as increased physical activity and a reasonable diet.